Healthtech_Leaders_horizontal


Healthtech Leaders Agenda

Day One | Day Two

Tuesday, June 21 - Break out sessions
(All times in EDT)


9:15am Health Tech CEO Forum

LSX Healthtech CEO Forum-1

Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of a US-based Healthtech and digital health company.

Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants. 

Please sign-up during registration.

Find out more


1:00pm Lunch



4:00pm Women’s Health CEO Forum

LSX Womens Health CEO Forum

The LSX Women’s Health CEO Forum provides a unique, powerful and valuable space for the candid sharing of ideas and experience between 20 of the sector's entrepreneurs, CEOs, CBOs, CFOs, CCOs and Chairs of Women’s Health companies. The forum is designed to foster new ideas and create new relationships between attendees so that they can leave with tangible outcomes and that will drive their businesses and the sector forward.

Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants. 

Please sign-up during registration.

Find out more


5:30pm Networking Drinks Reception

The networking drink reception takes place Tuesday, June 21. Attendees can look forward to a fantastic night of networking and double down on their event relationship building.

 

Wednesday, June 22 - Healthtech Leaders
(All times in EDT)



9:15am Chair’s opening remarks


9:20am Health Tech the hot point of digital opportunities and investment for US and European entrants

Health Tech and digital health innovations have exploded the sector over the last 18months due to the need for disruptive digital technology during and upcoming post pandemic world. Which in turn has seen growth in investment stakeholders, including new players in the market and seen an increase in European start-ups as well as North American companies seeking for investment to break into the US market. A panel of experts discuss:

  • What impact has Covid-19 had on health tech and digital health investment?
  • How do digital health companies typically demonstrate value?
  • Which value pools investors most excited about?

Robert Garber, Partner, 7WireVentures
Michael Greeley, General Partner, Flare Capital
Cris De Luca, Global Head, Digital Investments, Sanofi Ventures
Gaye Bok
, Partner, AI and Digital Innovation Fund, Mass General Brigham
Steve Tolle
, General Partner, HLM Venture Partners

Robert Garber, Partner, 7WireVentures    Michael Greeley, General Partner, Flare Capital Partners    Cris de Luca, Global Head, Digital Investments, Sanofi Ventures    Gaye Bok, Partner, AI and Digital Innovation Fund, Mass General Brigham    Steve Tolle, Partner, HLM Ventures-1


10:05am Leading the way with big tech, big data and big partnerships in healthcare: how the Tech leaders are positioning themselves to take on healthcare

With numerous digital opportunities across healthcare, how are leading tech and software players setting up strategic and market plays within the space. This panel will bring together tech and healthcare experts to discuss the key business roles of tech commercial leaders in healthcare, building out ecosystems and identifying future promising health applications the next 5 years.

Moderator: Will Morris, Healthcare Life Sciences Lead, Google
Elena Bonfiglioli
, Global Business Lead Healthcare, Strategy Lead Pharma Life Sciences, Microsoft

Lorraine Marchand, General Manager, Life Sciences, Watson Health, IBM
Brent Hicks
, Director, Technology and Innovation, Cleveland Clinic

Will Morris, Healthcare Life Sciences Lead, Google   Elena Bonfiglioli, Global Business Lead Healthcare, Strategy Lead Pharma Life Sciences, Microsoft    Lorraine Marchand, General Manager, Life Sciences, Watson Health, IBM    Brent Hicks, Director, Technology and Innovation, Cleveland Clinic


10:45am Coffee break and refreshments


11:15am The convergence of Pharma and digital health care: examining large Pharma' digital transformation through innovation, collaborations and acquisitions

The combination of digital pharmaceutical products and traditional drug products to target diseases are seen an ideal match to deliver improved patient care, but the execution is not so easy. The Pharmaceutical industry must build new strategy and business models to deliver digital health solutions to the market, which starts with the team and with an industry known to be not the fastest at the change, this panel will discuss the critical parameters required to bring Pharma truly into the digital world:

  • Deep diving into successful partnerships, who are the right collaborators for right now and the next 5 years
  • Quick wins for Pharma within digital health
  • The importance of the right team and mindset to move quickly in the digital space
  • The necessity of collaboration amongst the industry and healthcare systems

Amir Zur, Head of R&D, Digital Health, Takeda
Ethan Wergelis-Isaacson, Digital Health Strategy, Otsuka
Yacine Hadjiat, Global Head of Digital Solutions, Biogen Digital Health
Moderator: Jonathan Fox, Managing Director, Deloitte Digital

Amir Zur, Head of R&D, Digital Health, Takeda    Ethan Wergelis-Isaacson, Digital Health Strategy, Otsuka    Yacine Hadjiat, Global Head of Digital Solutions & Chief Medical Officer, Biogen Digital Health    Jonathan Fox, Managing Director, Deloitte


11:55pm De-risking commercialization within Health tech: Understanding how to work with payers and providers, secure US Health system partnerships to generate increase revenue streams and build on DTC opportunities to reduce uncertainty

To develop a successful health tech product line and secure long-term investment it is vital to show the company’s marketplace and value add to the healthcare space. In the first instance this is shown through consumer/patient data and revenue from DTC sales, as it’s the easiest route to market. But in a growing space how can digital health companies stand out to the consumer and streamline clinical development capabilities? And explore how to build partnerships with large employers, payers, and providers. A panel of experts from across these verticals will discuss how best to make these pivots and what type of partnerships they are looking for.

Moderator: Juan-Pablo Segura, Co-Founder and President, Babyscripts
Amy Waldron
, Global Leader, Healthcare & Life Sciences Solutions, Google Cloud - Health Plans, Google

Ben Linville-Engler, Chief Investment Strategist and Program Executive, MassTech

Juan-Pablo Segura, Co-Founder and President, Babyscripts    Amy Waldron, Global Leader, Healthcare & Life Sciences Solutions, Google Cloud - Health Plans, Google    Ben Linville-Engler, Chief Investment Strategist and Program Executive, Massachusetts Technology Collaborative


12:35pm Accessing the EU Digital Health Market: Regulatory Issues and Challenges

The value of the global digital health industry is predicted to grow from approximately $175 billion in 2019 to approximately $660 billion by 2025. Meanwhile, the COVID-19 pandemic has only highlighted the pivotal role that digital health technologies can play in our everyday lives. With rapid growth comes increased scrutiny and regulation however, and the EU has been very active in this area over the last number of years. This session will provide an overview of some key regulatory issues and challenges affecting stakeholders involved in the development and launch of digital products in the EU.

  • an overview of the core pieces of EU legislation that provide for the regulation of digital health products;
  • a summary of the enhanced requirements of the MDR and the effect on the digital health industry, a year down the line;
  • insights into the classification of digital health products under the MDR and particularly the application of Rule 11 on the classification of software;
  • a snapshot on reimbursement of digital health products in the EU; and
  • a look ahead to some important future legislation, such as the proposed AI Regulation, and possible impacts on the digital health sector.

James Gallagher, Life Sciences Regulatory Partner, Mason Hayes & Curran LLP

James Gallagher, Life Sciences Regulatory Partner, Mason Hayes & Curran LLP


1:00pm Lunch


2:00pm Women's Health - a deep dive into the growth potential, investment opportunities, strategic partnerships, and deal flows

In Health Tech the women’s health rose to $2.3 billion globally in 2021 and expected to surpass $10 by 2030. This dynamic field is set for growth following its initial breakthrough within a healthcare market play a few of years of go, but still has a quite a way to go. In this panel experts Women’s health leading companies, investment funds and Pharma leaders will discuss what is next for the field, how investments and deals are changing and what market opportunities are available for strategic partnerships.

Moderator: Delphine O’Rourke, Partner, Goodwin Procter
Lea Von Bidder
, Co-Founder and President, Ava Health

Maria Velissaris, Founding and General Partner, SteelSky Ventures
Jin Lee, Director of Digital Health, Rx+Global, Astellas Pharma US
Elizabeth Bailey
, Managing Director, Rhia Ventures
Jerrold Shapiro
, President, Floelle Inc.

Delphine O’Rourke, Partner, Goodwin Procter    Lea Von Bidder, Co-Founder and President, Ava Health    Maria Velissaris, Founding Partner, SteelSky Ventures    Jin Lee, Director of Digital Health, Rx+Global, Astellas Pharma US    Elizabeth Bailey, Managing Director, Rhia Ventures 300x    Jerrold Shapiro, President, Floelle Inc.


2:40pm Digital Therapeutics - a deep dive into the growth potential, investment opportunities, strategic partnerships, and deal flows

Building on the traction from the pandemic the global digital therapeutics market has increased from $2.47 billion in 2020 to an expected $3 billion in 2021 and predicted to reach over $23 billion by 2030, it is ripe for growth and investment. The initial surge was helped by loosen regulatory pathways but although it is clear the digital solutions are a value add to relieving the pressure in healthcare systems, there are critical hurdles still be addressed to increase adoption. A panel digital health and therapeutics experts discuss how to overcome the bottlenecks and how to build on the quick wins seen in areas such as remote patient monitoring tools:

Zach Henderson, Chief Commercial Officer, Glooko
Chris Wasden, Chief Strategy Officer, Happify Health
Gati Dharani, Director, Innovation Lab, Pfizer
Moderator: Leslie Gautam, Executive Director, Torreya

Zach Henderson, Chief Commercial Officer, Glooko    Chris Wasden, Head, Happify Health    Gati Dharani, Director, Innovation Lab, Pfizer    Leslie Gautam, Executive Director, Torreya


3:20pm Can we realise the potential of AI beyond quick wins in workflow process and progress integrated AI in Pharma?

The global market expected AI in Pharma was at $1.27 billion 2021, both are sizeable markets. This closing keynote panel will bring leaders in AI/ML, big data and genomics to discuss what is next, the quick wins around integrated AI drug discovery, how can genomics capitalise on increasing market size and the potential for these fields to grow together?

Moderator: Will Spagnoli, Chief Technology Officer, Phronesis Artificial Intelligence
Neil Sahota
, Artificial Intelligence Advisor, United Nations

Anthony Philippakis, Venture Partner, GV
Jiye Shi
, Associate VP, Head of Computational Design and Automation Platforms, Eli Lilly
Peter Henstock
, Machine Learning & AI Technical Lead, Pfizer
Sean McClain
, Founder & CEO, Absci

Will Spagnoli, Chief Technology Officer, Phronesis Artificial    Neil Sahota, United Nations Artificial Intelligence Advisor    Anthony Philippakis, Venture Partner, GV & Chief Data Officer, Broad Institute    Jiye Shi, Associate VP, Head of Computational Design and Automation Platforms, Eli Lilly    Peter Henstock, Machine Learning & AI Technical Lead, Pfizer    Sean McClain, Founder & CEO, Absci


4:00pm The full digital transformation of hospitals - the roadmap to set up increasing digital innovation within hospital starting with the patient-centric tools.

Full digital transformation is not easy in any sector, then throw in a pandemic at the key service at the epicentre of the pandemic – hospitals. At the same time the pandemic highlighted the need for digital innovation across the US hospital infrastructure, to remove bottlenecks within the healthcare systems and solution that truly puts the patient first. This panel will discuss the digitalisation journey happening in north America, how digital leaders are assigning their budgets, reviewing strategic partners and early and late-stage collaborations to build a digital framework for patent centric treatments and, whether digital medical devices, developing EHR/EMR systems or digital support services for surgical operations.

Adam Landman, VP, Chief Information and Digital Innovation Officer, Brigham & Women’s Hospital
Adam Dakin, Managing Director, Healthtech, Dreamit Ventures
Ivana Naeymi-Rad
, Chief Operating Officer, Intelligent Medical Objects

Adam Landman, VP, Chief Information and Digital Innovation Officer, Harvard University    Adam Dakin, Managing Director, Healthtech, Dreamit Ventures    Ivana Naeymi-Rad, Chief Operating Officer, Intelligent Medical Objects


4:40pm Chair’s closing remarks


4:45pm Close of Congress

 

DOWNLOAD BROCHURE